Elaine Shum, MD

I have always been very interested in science and decided to pursue a career in oncology after participating in cancer research as a high school student. At that time, oncology was becoming an innovative field. With the introduction of personalized medicine and the use of oral targeting agents, I saw how these new treatment options could greatly benefit patients. Inspired by this, I pursued a career in oncology, knowing that I would have the opportunity to make a difference through patient care and translational research.

At Perlmutter Cancer Center, I treat patients who have non-small cell lung cancer, small cell lung cancer, and other thoracic cancers. Cancer is a life-changing diagnosis for many people and I am passionate about providing care and helping people through their journey.

As a physician, I value open communication and building relationships with my patients so they feel comfortable asking me questions. I believe in shared decision-making and taking the time to help each person understand his or her diagnosis and treatment plan. At the Lung Cancer Center, I am fortunate to be part of a team that believes in excellent patient care and offers the latest cancer treatments through research and ongoing clinical trials.

My recent research has focused on epidermal growth factor receptor gene mutations in non-small cell lung cancer. These mutations are more prevalent in minority populations who are usually underrepresented in major clinical trials. I hope to develop more research to determine specific treatments for these populations and other targeted mutations.

I am a member of several leading societies including the American Society of Clinical Oncology, the American Society of Hematology, the American Association for Cancer Research, and the International Association for the Study of Lung Cancer.